When increasing SnC6 to 2 μM, fVII-tPDT was able to completely eradicate CD133+ CSCs, CD133- non-CSCs and parental H460 and A549 lung cancer cells (Figure 4a and 4b and Supplementary Table S3). The gene discussed is PROM1; the disease is lung carcinoma.